cheaptrix/billsum-US_congress_and_house huggingface dataset:
Protecting Americans from Fentanyl Trafficking Act of 2021

To codify the temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of the Controlled Substances Act. 1. Short title This Act may be cited as the Protecting Americans from Fentanyl Trafficking Act of 2021 2. Placement of fentanyl-related substances in schedule I Schedule I of section 202(c) of the Controlled substances Act ( 21 U.S.C. 812(c) (e) (1) Fentanyl-related substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers. (2) For purposes of paragraph (1), the term fentanyl-related substance (A) is not listed in another schedule; (B) has not been approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 (C) is structurally related to fentanyl by— (i) replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle; (ii) substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups; (iii) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups; (iv) replacement of the aniline ring with any aromatic monocycle, whether or not further substituted in or on the aromatic monocycle; or (v) replacement of the N-propionyl group by another acyl group. .

Summary: Protecting Americans from Fentanyl Trafficking Act of 2021 This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on January 28, 2022.
Preserving Accountability for National Assets Act of 2021

To establish a Venezuela Reconstruction Fund, and for other purposes. 1. Short title This Act may be cited as the Preserving Accountability for National Assets Act of 2021 PANA Act 2. Venezuela Restoration Fund (a) Establishment There is established in the United States Treasury a fund, to be known as the Venezuela Restoration Fund (b) Uses Amounts in the Fund— (1) shall be available to the Secretary of State only for the purposes described in paragraph (2), without fiscal year limitation or need for subsequent appropriation; (2) shall be used only for the purposes of— (A) strengthening democratic governance and institutions, including the democratically elected National Assembly of Venezuela; (B) defending internationally recognized human rights for the people of Venezuela, including support for efforts to document crimes against humanity and violations of human rights; (C) supporting the efforts of independent media outlets to broadcast, distribute, and share information beyond the limited channels made available by the Maduro regime; and (D) combatting corruption and improving the transparency and accountability of institutions that are part of the Maduro regime; (3) may support governmental and nongovernmental parties in advancing the purposes described in paragraph (2); and (4) shall be allocated in a manner complementary to existing United States foreign assistance, diplomacy, and anti-corruption activities. (c) Funding Beginning on or after the date of the enactment of this Act, notwithstanding any other provision of law, in the case of any funds or assets forfeited to the United States by an individual or entity connected to the regimes of Hugo Chávez and Nicolás Maduro in Venezuela, the funds or assets will be deposited in the Venezuela Reconstruction Fund established under subsection (a). (d) Reporting Not later than 1 year after the date of the enactment of this Act and not less frequently than annually thereafter, the Secretary of State shall submit a report to the appropriate congressional committees that includes— (1) an accounting of the amount and sources of funds that have been deposited into the Venezuela Restoration Fund; and (2) a summary of the obligation, amounts, and expenditure of such funds.

Summary: Preserving Accountability for National Assets Act of 2021 or the PANA Act This bill establishes the Venezuela Restoration Fund to strengthen democratic governance and institutions, defend human rights, support independent media outlets, and combat corruption and improve transparency in Venezuela. Any funds or assets forfeited to the United States by an individual or entity connected to the regimes of Hugo Chávez and Nicolás Maduro in Venezuela will be deposited into this fund.
Chronic Disease Management Act of 2021

To amend the Internal Revenue Code of 1986 to permit high deductible health plans to provide chronic disease prevention services to plan enrollees prior to satisfying their plan deductible. 1. Short title This Act may be cited as the Chronic Disease Management Act of 2021 2. Chronic disease prevention (a) In general Section 223(c)(2) (F) Preventive care services and items for chronic conditions For purposes of subparagraph (C)— (i) preventive care shall include any service or item used to treat an individual with a chronic condition if— (I) such service or item is low-cost, (II) in regards to such service or item, there is medical evidence supporting high cost efficiency of preventing exacerbation of the chronic condition or the development of a secondary condition, and (III) there is a strong likelihood, documented by clinical evidence, that with respect to the class of individuals utilizing such service or item, the specific service or use of the item will prevent the exacerbation of the chronic condition or the development of a secondary condition that requires significantly higher cost treatments, and (ii) an individual who has been prescribed preventive care for any chronic condition may be presumed to have been diagnosed with such condition if such preventive care is customarily prescribed for such condition. . (b) Effective date The amendment made by this section shall apply to coverage for months beginning after the date of the enactment of this Act.

Summary: Chronic Disease Management Act of 2021 This bill modifies requirements for health savings accounts (HSAs) to permit the high deductible health plans required for an HSA to provide care for chronic conditions with no deductible. The bill covers any preventive care service or item used to treat a chronic condition if (1) such service or item is low-cost, (2) there is medical evidence of the effectiveness of such service or item, and (3) there is a strong likelihood that the use of such service or item will prevent the exacerbation of the chronic condition or the development of a secondary condition that requires significantly higher cost treatment. The bill further provides that an individual who has been prescribed preventive care for any chronic condition may be presumed to have been diagnosed with such condition if such preventive care is customarily prescribed for such condition.
CURB Debt Collectors Act

To amend the Small Business Act to prevent predatory debt collectors from receiving paycheck protection program loans, and for other purposes. 1. Short title This Act may be cited as the Ceasing Undeserved Relief Benefits for Debt Collectors Act for 2021 CURB Debt Collectors Act 2. Debt collectors ineligible for paycheck protection program loans (a) In general Section 7(a) of the Small Business Act ( 15 U.S.C. 636(a) (1) in paragraph (36), by adding at the end the following: (W) Debt collectors ineligible An individual or entity shall be ineligible to receive a covered loan if— (i) the individual or entity is a debt collector, as defined in section 803 of the Fair Debt Collection Practices Act ( 15 U.S.C. 1692a (ii) the individual or entity has been found to have violated of any provision of the Fair Debt Collection Practices Act ( 15 U.S.C. 1692 (I) an adjudication by a Federal agency or an action brought in a court of competent jurisdiction if the adjudication or action constitutes an exercise of enforcement authority under section 814 of such Act ( 15 U.S.C. 1692l (II) any other action brought in a court of competent jurisdiction; (iii) the adjudication or action described in clause (ii) was not resolved by a settlement agreement or consent decree that remains in effect as of the date on which the individual or entity applies for the covered loan if the adjudication or action was brought by a Federal agency; and (iv) a final order or final judgment against the individual or entity pursuant to an adjudication or action described in clause (ii), as appropriate— (I) is issued or entered, as appropriate, during the 10-year period ending on the date on which the individual or entity applies for the covered loan; (II) has not been overturned; and (III) is no longer subject to appeal. ; and (2) in paragraph (37)(A)(iv)(III)— (A) in item (dd), by striking or (B) in item (ee), by striking ; and ; or (C) by adding at the end the following: (ff) an individual or entity that, under subparagraph (W) of paragraph (36), is ineligible for a covered loan under such paragraph; and . (b) Applicability The amendments made by subsection (a) shall not apply with respect to any loan made prior to date of enactment of this Act.

Summary: Ceasing Undeserved Relief Benefits for Debt Collectors Act for 2021 or the CURB Debt Collectors Act This bill makes debt collectors that have violated certain debt collection laws ineligible to receive loans under the Paycheck Protection Program established to support small business in response to COVID-19.
Metropolitan Statistical Area Stabilization Act

To prohibit the Director of the Office of Management and Budget from raising the minimum urban area population to qualify a metropolitan statistical area from 50,000, and for other purposes. 1. Short title This Act may be cited as the Metropolitan Statistical Area Stabilization Act 2. Prohibition and study on metropolitan statistical area designation The Director of the Office of Management and Budget shall not raise the minimum urban area population to qualify a metropolitan statistical area from 50,000.

Summary: Metropolitan Statistical Area Stabilization Act This bill prohibits the Office of Management and Budget from raising the minimum urban area population to qualify a metropolitan statistical area from 50,000.
Guarding Readiness Resources Act of 2021

To provide for the crediting of funds received by the National Guard Bureau as reimbursement from States. 1. Short title This Act may be cited as the Guarding Readiness Resources Act of 2021 2. Treatment of funds received by National Guard Bureau as reimbursement from States Section 710 of title 32, United States Code, is amended by adding at the end the following new subsection: (g) Treatment of reimbursed funds Any funds received by the National Guard Bureau from a State, the Commonwealth of Puerto Rico, the District of Columbia, Guam, or the Virgin Islands as reimbursement under this section for the use of military property shall be credited to— (1) the appropriation, fund, or account used in incurring the obligation; or (2) an appropriate appropriation, fund, or account currently available for the purposes for which the expenditures were made. .

Summary: Guarding Readiness Resources Act of 2021 This bill modifies the treatment of funds received by the National Guard Bureau as a reimbursement from a state or other U.S. territory (e.g., Guam) for the use of military property. Specifically, the funds must be credited to (1) the appropriation, fund, or account used in incurring the obligation; or (2) an appropriation, fund, or account currently available for the purposes of which the expenditures were made.
Protecting Americans from Dangerous Opioids Act

To require the Food and Drug Administration to revoke the approval of one opioid pain medication for each new opioid pain medication approved. 1. Short title This Act may be cited as the Protecting Americans from Dangerous Opioids Act 2. Findings Congress finds as follows: (1) Opioids killed more than 36,000 people in the United States in 2019, more than any year on record. In 2019, nearly half of all drug overdose deaths involved a prescription opioid or synthetic opioid. (2) According to the Centers for Disease Control, 3 out of 4 new heroin users abused prescription opioids before moving to heroin. (3) The United States makes up only 4.6 percent of the world's population, but consumes 80 percent of its opioid pain medications. (4) In 2012, health care providers wrote 259,000,000 prescriptions for painkillers, enough for every individual in the United States to have a bottle of pills. (5) The amount of prescription opioids sold in the United States has nearly quadrupled since 1999 without a reported increase in pain. At the same time overdose deaths involving opioids have also quadrupled since 1999. (6) In 2020, over 90,000 people are predicted to have died of drug overdose, the highest number on record. 3. Requirement to revoke approval (a) In general Notwithstanding any other provision of law, if the Secretary of Health and Human Services (referred to in this section as the Secretary 21 U.S.C. 355 (b) Considerations In determining the drug for which the Secretary will revoke approval pursuant to subsection (a), the Secretary shall— (1) prioritize revocation of non-abuse deterrent formulations of opioid drugs; and (2) consider the public health impact of the opioid drug being on the market.

Summary: Protecting Americans from Dangerous Opioids Act This bill requires the Food and Drug Administration (FDA) to revoke approval for an opioid drug for every new opioid drug approved. (Opioids are drugs with effects similar to opium, such as certain pain medications.) In determining the drug for which to revoke approval, the FDA must prioritize revoking approval for drugs that are not abuse deterrent and consider the public health impact of drugs on the market.
Changing the Culture of the FDA Act

To direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration. 1. Short title This Act may be cited as the Changing the Culture of the FDA Act 2. Mission Statement of the Food and Drug Administration The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall amend the mission statement of the Food and Drug Administration to include the following statement: The FDA is also responsible for protecting the public health by strongly considering the danger of addiction and overdose death associated with prescription opioid medications when approving these medications and when regulating the manufacturing, marketing, and distribution of opioid medications.

Summary: Changing the Culture of the FDA Act This bill requires the Food and Drug Administration to amend its mission statement to state that it is responsible for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)
FDA Accountability for Public Safety Act

To establish procedures regarding the approval of opioid drugs by the Food and Drug Administration. 1. Short title This Act may be cited as the FDA Accountability for Public Safety Act 2. Approval against the recommendation of the FDA advisory committee on opioid drugs (a) In General Any approval of an application or supplement to an application under section 505(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(b) Public Law 114–198 Commissioner (b) Reports to Congress If the Commissioner approves a drug as described in subsection (a), the Commissioner shall— (1) submit a report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, and to any member of Congress that requests the report, that includes— (A) medical and scientific evidence regarding patient safety that clearly supports the Commissioner's decision to approve the opioid drug against the recommendation of the advisory committee; and (B) a disclosure of any potential conflicts of interest that may exist regarding any official of the Food and Drug Administration who was involved in the decision to approve the drug prior to the Commissioner's final decision under subsection (a); and (2) at the request of the Committee on Health, Education, Labor, and Pensions of the Senate or the Committee on Energy and Commerce of the House of Representatives, testify before that committee regarding the Commissioner's decision to approve the opioid drug against the recommendation of the advisory committee. (c) Prohibition on marketing A drug approved as described in subsection (a) shall not be introduced or delivered for introduction into interstate commerce until the report described in subsection (b)(1) has been submitted to Congress. (d) Scope of advisory committee review Section 106(a)(1)(A) of the Comprehensive Addiction and Recovery Act of 2016 ( Public Law 114–198 (1) by inserting , or supplement to an application, application (2) by striking of a new for a

Summary: FDA Accountability for Public Safety Act This bill establishes additional procedures related to the market approval process for opioids. Under the bill, a Food and Drug Administration (FDA) advisory committee must make recommendations regarding supplemental applications for opioids. Current law requires only that an FDA committee make recommendations on new drug applications. The bill specifies that only the Commissioner of Food and Drugs may approve an opioid-related application against the recommendation of the committee. If the Commissioner approves such an application against a committee recommendation, the Commissioner must submit a report to Congress that includes (1) the evidence regarding patient safety that supports the Commissioner's decision, and (2) a disclosure of any potential conflicts of interest of FDA officials involved in the decision. The Commissioner must also testify before Congress regarding the decision, upon request. The drug in question may not be sold until the Commissioner has submitted the required report.
Abandoned Mine Land Reclamation Fee Extension Act

To amend the Surface Mining Control and Reclamation Act of 1977 to extend the period during which certain reclamation fees are required to be paid. 1. Short title This Act may be cited as the Abandoned Mine Land Reclamation Fee Extension Act 2. Abandoned mine land reclamation fee Section 402(b) of the Surface Mining Control and Reclamation Act of 1977 ( 30 U.S.C. 1232(b) September 30, 2021 September 30, 2036

Summary: Abandoned Mine Land Reclamation Fee Extension Act This bill extends through FY2036 the reclamation fee that each operator of a coal mining operation must pay to the Department of the Interior for the Abandoned Mine Reclamation Fund. Under the existing Abandoned Mine Land Reclamation Program, Interior collects a fee from coal mining companies for each ton of coal produced. The fees are deposited into the fund, which may be used to address hazards to public health, safety, and the environment from coal mining sites that were abandoned or unreclaimed as of August 3, 1977. Interior's authority to collect the fee expires on September 30, 2021.
Moving Americans Privacy Protection Act

To amend the Tariff Act of 1930 to protect personally identifiable information, and for other purposes. 1. Short title This Act may be cited as the Moving Americans Privacy Protection Act 2. Protection of personally identifiable information (a) In general Paragraph (2) of section 431(c) of the Tariff Act of 1930 ( 19 U.S.C. 1431(c) (2) (A) The information listed in paragraph (1) shall not be available for public disclosure if— (i) the Secretary of the Treasury makes an affirmative finding on a shipment-by-shipment basis that disclosure is likely to pose a threat of personal injury or property damage; or (ii) the information is exempt under the provisions of section 552(b)(1) of title 5, United States Code. (B) The Secretary shall ensure that any personally identifiable information, including Social Security numbers and passport numbers, is removed from any manifest signed, produced, delivered, or electronically transmitted under this section before access to the manifest is provided to the public. . (b) Effective date The amendment made by subsection (a) shall take effect on the date that is 30 days after the date of the enactment of this Act.

Summary: Moving Americans Privacy Protection Act This bill revises requirements regarding the public disclosure of personally identifiable information contained in the manifest of vessels or aircraft entering a U.S. port or place. The bill directs the Department of the Treasury to remove such information, including social security numbers and passport numbers, from a manifest signed and transmitted to Treasury before it is accessible by the public.
World Bank Integrity Preservation Act of 2021

To require the United States Executive Director of the International Bank for Reconstruction and Development to oppose assistance by the Bank for any country that exceeds the graduation threshold of the Bank and is of concern with respect to religious freedom. 1. Short title This Act may be cited as the World Bank Integrity Preservation Act of 2021 2. Opposition to assistance by the International Bank for Reconstruction and Development for countries that exceed the graduation threshold and are of concern for religious freedom The United States Governor of the International Bank for Reconstruction and Development shall instruct the United States Executive Director of the Bank to vote against, and to use the Executive Director’s best efforts to deny, any loan or the extension of any financial or technical assistance by the Bank to a country if— (1) the gross national income per capita of the country exceeds, by more than 35 percent, the threshold for graduation from eligibility for assistance from the Bank; (2) the reserves of the country exceed an amount equivalent to the value of goods and services imported into the country during the most recent 12-month period for which data are available; and (3) the country is designated— (A) as a country of particular concern for religious freedom under clause (ii) of section 402(b)(1)(A) of the International Religious Freedom Act of 1998 ( 22 U.S.C. 6442(b)(1)(A) (B) for placement on the special watch list under clause (iii) of that section.

Summary: World Bank Integrity Preservation Act of 2021 This bill requires the U.S. Executive Director of the International Bank for Reconstruction and Development to oppose any extension of financial or technical assistance by the bank to a country that both exceeds the graduation threshold of the bank and is designated as a country of particular concern for religious freedom.